Related Experiment Video
Updated: Apr 17, 2026
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.3K
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer
Eduardo Bonavita1, Stefania Gentile1, Marcello Rubino1
1Humanitas Clinical and Research Center, Rozzano (Milan) 20089, Italy.
Cell
|February 14, 2015
Summary
Pentraxin 3 (PTX3), a key innate immunity protein, acts as an oncosuppressor by regulating inflammation and complement activation. Its deficiency increases cancer susceptibility by promoting tumor growth and macrophage recruitment.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Pentraxin 3 (PTX3) is crucial for innate immunity and inflammation regulation.
- PTX3 interacts with complement factors C1q and Factor H, modulating the complement cascade.
- PTX3 deficiency is linked to increased susceptibility to carcinogenesis.
Purpose of the Study:
- To investigate the role of PTX3 in cancer development and regulation.
- To elucidate the mechanisms by which PTX3 deficiency promotes tumor growth.
- To explore the epigenetic regulation of PTX3 in human tumors.
Main Methods:
- Utilized gene-targeted Ptx3(-/-) mice to study carcinogenesis.
- Analyzed macrophage infiltration, cytokine production, and angiogenesis in Ptx3(-/-) mice.
- Investigated epigenetic regulation (promoter methylation) of PTX3 in human tumors.
Main Results:
- Ptx3(-/-) mice exhibited increased susceptibility to carcinogenesis, with enhanced inflammation and Trp53 mutations.
- PTX3 deficiency amplified complement activation, CCL2 production, and recruitment of tumor-promoting macrophages.
- Epigenetic silencing of PTX3 via promoter methylation was observed in human tumors like leiomyosarcomas and colorectal cancer.
Conclusions:
- PTX3 functions as an extrinsic oncosuppressor gene in both mice and humans.
- PTX3 regulates complement-dependent, macrophage-mediated inflammation that promotes tumor development.
- Targeting PTX3 or its regulatory pathways may offer therapeutic strategies for cancer.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.6K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
961
Related Concept Videos
02:17The Tumor Microenvironment
8.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
01:31The Intrinsic Apoptotic Pathway
9.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
03:03mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
01:17The Extrinsic Apoptotic Pathway
9.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
02:23Abnormal Proliferation
5.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
01:25Selectins
4.9K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.9K